The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 14, 2019 at 10:12 AM.

  1. #1 cafead, Oct 14, 2019 at 10:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Biotech stocks continued to languish for a third straight week. Negative broader market sentiment and company-specific weakness weighed down on the sector.

    Pfenex Inc (NYSE: PFNX) received FDA approval for its biosimilar to Amgen, Inc. (NASDAQ: AMGN)'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: CLVLY)'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory agency.

    The week also saw the listing of two biotechs following their initial public offerings.

    The following are some of the key catalysts for biotech stocks in the upcoming week.

    article source
     
    Quote

Reply to Thread